| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |